27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
BRAINTREE, Mass., Dec. 22, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2018 at 3:00pm Pacific time / 6:00pm Eastern time.
The public may access Mr. Simon's presentation live via webcast at: https://jpmorgan.metameetings.net/events/healthcare18/sessions/13533-haemonetics-corporation/webcast.
ABOUT HAEMONETICS
Haemonetics (NYSE:HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.
INVESTOR CONTACT
Gerry Gould, VP-Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com
SOURCE Haemonetics Corporation
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!